Philippe Motté

Part of BPCE SA, Natixis Corporate & Investment Bank SA is a French company that provides investment and financial services. The company is based in Paris, France.

Amanys Pharma engages in the manufacture, distribution and wholesale of generic drugs. It offers antibiotics and, niche products (plasma factors for treating hemophilia, chemotherapy supplements, painkillers). The company was founded in 2011 and is headquartered in Rabat, Morocco.

Brown Advisory, Inc. provides investment and advisory services. It specializes in investment management, strategic advisory, wealth management, and private equity. The firm provides services to individuals, families, institutions, and corporations. The company was founded in 1993 and is headquartered in Baltimore, MD.

Mckinsey & Co. SAS provides business and management consulting services. The company is headquartered in Paris, France.

Eli Lilly Italia SpA manufactures pharmaceutical products. The company was founded by Colonel Eli Lilly in 1876 and is headquartered in Sesto Fiorentino, Italy.

Future Pharmaceutical Industries engages in the manufacture of pharmaceutical products. Its products include antivirals, analgesic and anti-inflammatory, anti-infective, Neuro and psychiatry, cardio and metabolic, gastrointestinal, and miscellaneous. The company was founded in 2011 and is headquartered in Badr City, Egypt.

Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.

Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

Dragon Financial Partners Ltd. provides advisory services. The private company is based in Hong Kong, Hong Kong.

Clinical Genomics Technologies Pty Ltd. manufactures and sells healthcare solutions for the early detection and prevention of disease. The company was founded by Lawrence LaPointe, Richard J. Sands and Susanne K. Pedersen in September 2006 and is headquartered in North Ryde, Australia.

Actelion Pharmaceuticals UK Ltd. discovers, develops, and markets drugs. Its products are Tracleer for the treatment of pulmonary arterial hypertension and Zavesca, which is used to treat Type 1 Gaucher disease. The company is headquartered in London, UK.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland.

IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.

Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.

Greer Laboratories, Inc. develops and provides allergy immunotherapy products and services for treating humans and animals. The company was founded in 1904 and is headquartered in Lenoir, NC.

Finorpa Gie (Finorpa) is a Private Equity firm founded in 1984. Finorpa Gie is headquartered in Paris, France.

AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France.